IDR 2360.0
(-2.07%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 741.05 Billion IDR | -5.74% |
2022 | 786.2 Billion IDR | -15.99% |
2021 | 935.82 Billion IDR | 9.43% |
2020 | 855.18 Billion IDR | 9.16% |
2019 | 783.43 Billion IDR | 22.51% |
2018 | 639.49 Billion IDR | -6.17% |
2017 | 681.52 Billion IDR | 26.26% |
2016 | 539.77 Billion IDR | 22.44% |
2015 | 440.83 Billion IDR | 25.78% |
2014 | 350.49 Billion IDR | -22.41% |
2013 | 451.75 Billion IDR | 33.32% |
2012 | 338.84 Billion IDR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 846.89 Billion IDR | -33.85% |
2024 Q2 | 1280.28 Billion IDR | 45.48% |
2024 Q1 | 880.03 Billion IDR | 18.75% |
2023 Q4 | 741.05 Billion IDR | -3.58% |
2023 Q2 | 661.58 Billion IDR | -11.86% |
2023 FY | 741.05 Billion IDR | -5.74% |
2023 Q1 | 750.63 Billion IDR | -4.52% |
2023 Q3 | 768.59 Billion IDR | 16.17% |
2022 Q2 | 804.89 Billion IDR | -16.7% |
2022 Q4 | 786.2 Billion IDR | -8.96% |
2022 FY | 786.2 Billion IDR | -15.99% |
2022 Q1 | 966.31 Billion IDR | 3.26% |
2022 Q3 | 863.56 Billion IDR | 7.29% |
2021 FY | 935.82 Billion IDR | 9.43% |
2021 Q1 | 967.16 Billion IDR | 13.09% |
2021 Q2 | 868.17 Billion IDR | -10.24% |
2021 Q4 | 935.82 Billion IDR | 3.79% |
2021 Q3 | 901.63 Billion IDR | 3.85% |
2020 Q2 | 1059.45 Billion IDR | 29.47% |
2020 FY | 855.18 Billion IDR | 9.16% |
2020 Q4 | 855.18 Billion IDR | 3.99% |
2020 Q3 | 822.41 Billion IDR | -22.37% |
2020 Q1 | 818.31 Billion IDR | 4.45% |
2019 Q3 | 758.12 Billion IDR | 6.14% |
2019 Q2 | 714.26 Billion IDR | -8.67% |
2019 Q1 | 782.04 Billion IDR | 22.29% |
2019 Q4 | 783.43 Billion IDR | 3.34% |
2019 FY | 783.43 Billion IDR | 22.51% |
2018 FY | 639.49 Billion IDR | -6.17% |
2018 Q1 | 688.6 Billion IDR | 1.04% |
2018 Q2 | 652.56 Billion IDR | -5.23% |
2018 Q3 | 718.23 Billion IDR | 10.06% |
2018 Q4 | 639.49 Billion IDR | -10.96% |
2017 Q3 | 513.01 Billion IDR | -50.03% |
2017 Q4 | 681.52 Billion IDR | 32.85% |
2017 FY | 681.52 Billion IDR | 26.26% |
2017 Q1 | 535.79 Billion IDR | -0.74% |
2017 Q2 | 1026.58 Billion IDR | 91.6% |
2016 FY | 539.77 Billion IDR | 22.44% |
2016 Q1 | 486.54 Billion IDR | 10.37% |
2016 Q2 | 515.3 Billion IDR | 5.91% |
2016 Q3 | 499.51 Billion IDR | -3.06% |
2016 Q4 | 539.77 Billion IDR | 8.06% |
2015 Q2 | 661.1 Billion IDR | 66.52% |
2015 FY | 440.83 Billion IDR | 25.78% |
2015 Q4 | 440.83 Billion IDR | 20.6% |
2015 Q3 | 365.55 Billion IDR | -44.71% |
2015 Q1 | 397 Billion IDR | 13.27% |
2014 Q1 | - IDR | 0.0% |
2014 Q3 | 230.56 Billion IDR | 0.0% |
2014 FY | 350.49 Billion IDR | -22.41% |
2014 Q4 | 350.49 Billion IDR | 52.01% |
2013 FY | 451.75 Billion IDR | 33.32% |
2012 FY | 338.84 Billion IDR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
PT Bundamedik Tbk | 1283.12 Billion IDR | 42.246% |
PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | 28.695% |
PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 79.44% |
PT Murni Sadar Tbk | 708.74 Billion IDR | -4.559% |
PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | 58.119% |
PT Royal Prima Tbk | 49.68 Billion IDR | -1391.503% |
PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | -854.557% |
PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | 46.345% |
PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | 74.746% |
PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 80.232% |